Zoledronic acid 4mg/5ml solution for infusion vials
NHS hospitals in England used £17,839,569 of indicative cost of Zoledronic acid 4mg/5ml solution for infusion vials in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 1.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Zoledronic acid 4mg/5ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Zoledronic acid 4mg/5ml solution for infusion vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £856,583 |
| Leeds Teaching Hpls Nhs Trust | £655,754 |
| Nottingham University Hospitals Trust | £648,419 |
| Sheffield Teaching Hospitals Nhs Trust | £642,227 |
| The Clatterbridge Cancer Centre Nhs Ft | £620,593 |
| University Hpls Of Leicester Nhs Trust | £540,779 |
| Norfolk & Norwich University Hpl Nhs Trt | £528,905 |
| Royal Cornwall Hospitals Nhs Trust | £463,077 |
| St George's Univ Hosps Foundation Nhst | £439,596 |
| Imperial College Healthcare Nhs Trust | £430,898 |
The primary-care picture
Zoledronic acid is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Zoledronic acid medicine page.